SCM
MED icon

Symons Capital Management’s Medifast MED Stock Holding History

Symons Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,870
Closed -$306K – 77
2013
Q2 		$306K Buy
+11,870
New +$312K 0.08% 64

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
GOFM
GGC Opportunity Fund Management San Francisco, California $526M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Symons Capital Management's MED Position: Q3 2013 in Review

Symons Capital Management sold out of Medifast (MED) in Q3 2013, closing a stake of 11,870 shares — an estimated $306K sold.

Symons Capital Management first reported a position in MED in Q2 2013 and held it in 1 quarter. The position peaked at $306K in Q2 2013. 140 funds tracked by Wall St. Rank hold MED as of Q3 2013.

  • Symons Capital Management reported no remaining Medifast position as of Q3 2013 after selling out during the quarter.
  • Symons Capital Management sold 11,870 Medifast shares in Q3 2013, an estimated $306K.
  • Symons Capital Management first reported a position in Medifast in Q2 2013 and held it in 1 quarter.
  • Symons Capital Management's Medifast position peaked at $306K in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Medifast as of Q3 2013.

Based on Symons Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.